Anti-IL-23R peptide now in oral form! Very successful against psoriasis.
Anti-IL-23R peptide now in oral form! Very successful against psoriasis.
Hello
Hello
Just sayin
🦄
Just sayin
🦄
"Even when these affected areas cover a small percentage of the body, they often do not respond to topical creams…"
—Richard Warren, U. Manchester (lead author; paid J&J consultant)
Icotyde pill: approved 12+. Infection risk.
"Even when these affected areas cover a small percentage of the body, they often do not respond to topical creams…"
—Richard Warren, U. Manchester (lead author; paid J&J consultant)
Icotyde pill: approved 12+. Infection risk.
J&J's oral peptide Icotyde: 70% clear or almost clear at week 112 in people with hard-to-treat spots like the scalp, hands and feet (Phase 3).
The catch: J&J-funded, not yet peer-reviewed.
FDA-approved for plaque psoriasis, 12+.
J&J's oral peptide Icotyde: 70% clear or almost clear at week 112 in people with hard-to-treat spots like the scalp, hands and feet (Phase 3).
The catch: J&J-funded, not yet peer-reviewed.
FDA-approved for plaque psoriasis, 12+.
#Psoriasis
psoriasisclub.org/thread-8487....
#Psoriasis
psoriasisclub.org/thread-8487....